A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia-Reference-Cited by-同舟云学术

A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia

Published:2015-03-15 Issue:4 Volume:110 Page:646-655
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Burns Lucy¹,Gisev Natasa¹,Larney Sarah¹²,Dobbins Timothy³,Gibson Amy⁴,Kimber Jo¹,Larance Briony¹,Mattick Richard P.¹,Butler Tony⁵⁶,Degenhardt Louisa¹^ORCID

Affiliation:

1. National Drug and Alcohol Research Centre; University of NSW; Sydney Australia

2. Alpert Medical School; Brown University; Providence Rhode Island USA

3. National Centre for Epidemiology and Population Health; Australian National University; Canberra Australia

4. Centre for Health Research; University of Western Sydney; Sydney Australia

5. Kirby Institute; University of NSW; Sydney Australia

6. Australia School of Public Health and Community Medicine; University of NSW; Sydney Australia

Funder

Australian National Health and Medical Research Council (NHMRC)

L.D.

S.L.

B.L.

R.P.M.

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/add.12834/fullpdf

Reference11 articles.

1. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence;Mattick;Cochrane Database Syst Rev,2003

2. Pharmacology of opioid agonists and antagonists

3. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence;Mattick;Cochrane Database Syst Rev,2014

4. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients;Mattick;Addiction,2003

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishing a research agenda for the study and assessment of opioid withdrawal;The Lancet Psychiatry;2024-07

2. Opioid Agonist Treatment Retention Among People Initiating Methadone and Buprenorphine Across Diverse Demographic and Geographic Subgroups in Ontario: A Population-based Retrospective Cohort Study;Canadian Journal of Addiction;2023-12

3. Risk of opioid-related mortality associated with buprenorphine versus methadone: A systematic review of observational studies;2023-08-16

4. Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: Secondary analysis of a pragmatic randomized trial;Drug and Alcohol Dependence;2023-07

5. Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder;Drug and Alcohol Dependence;2023-06